Abstract: Embodiments detect fraud of risk targets that include both customer accounts and cashiers. Embodiments receive historical point of sale (“POS”) data and divide the POS data into store groupings. Embodiments create a first aggregation of the POS data corresponding to the customer accounts and a second aggregation of the POS data corresponding to the cashiers. Embodiments calculate first features corresponding to the customer accounts and second features corresponding to the cashiers. Embodiments filter the risk targets based on rules and separate the filtered risk targets into a plurality of data ranges. For each combination of store groupings and data ranges, embodiments train an unsupervised machine learning model. Embodiments then apply the unsupervised machine learning models after the training to generate first anomaly scores for each of the customer accounts and cashiers.

Abstract: Embodiments detect fraud of risk targets that include both customer accounts and cashiers. Embodiments receive historical point of sale (“POS”) data and divide the POS data into store groupings. Embodiments create a first aggregation of the POS data corresponding to the customer accounts and a second aggregation of the POS data corresponding to the cashiers. Embodiments calculate first features corresponding to the customer accounts and second features corresponding to the cashiers. Embodiments filter the risk targets based on rules and separate the filtered risk targets into a plurality of data ranges. For each combination of store groupings and data ranges, embodiments train an unsupervised machine learning model. Embodiments then apply the unsupervised machine learning models after the training to generate first anomaly scores for each of the customer accounts and cashiers.

Abstract: The present invention relates to the field of gels. The invention also relates to an improved method for manufacturing gels. In particular the invention relates to a new class of material, fluid-bicontinuous particle-stabilized gels, and a method of making the same. The fluid-bicontinuous particle-stabilized gels comprise at least a first fluid, a second fluid, and a continuous layer of particles positioned at a continuous interface between the first fluid and the second fluid.

Abstract: A method of making a microparticle that contains DNA coding for a polypeptide is described in which a solvent extraction method is used and solvent extraction takes place at elevated temperature. Oral administration of the microparticle leads to its expression. DNA coding for an immunogen is for stimulating antibody formation in a recipient and DNA coding for a non-immunogenic polypeptide is for gene therapy applications. DNA is incorporated into the microparticle without destruction of its function.

Abstract: A microparticle contains DNA coding for a polypeptide and oral administration of the microparticle leads to its expression. DNA coding for an immunogen is for stimulating antibody formation in a recipient and DNA coding for a non-immunogenic polypeptide is for gene therapy applications. DNA is incorporated into the microparticle without destruction of its function.

Abstract: A microparticle contains DNA coding for a polypeptide and oral administration of the microparticle leads to its expression. DNA coding for an immunogen is for stimulating antibody formation in a recipient and DNA coding for a non-immunogenic polypeptide is for gene therapy applications. DNA is incorporated into the microparticle without destruction of its function.

Abstract: A method of making a microparticle that contains DNA coding for a polypeptide is described in which a solvent extraction method is used and solvent extraction takes place at elevated temperature. Oral administration of the microparticle leads to its expression. DNA coding for an immunogen is for stimulating antibody formation in a recipient and DNA coding for a non-immunogenic polypeptide is for gene therapy applications. DNA is incorporated into the microparticle without destruction of its function.

Abstract: A method of making a microparticle that contains DNA coding for a polypeptide is described in which a solvent extraction method is used and solvent extraction takes place at elevated temperature. Oral administration of the microparticle leads to its expression. DNA coding for an immunogen is for stimulating antibody formation in a recipient and DNA coding for a non-immunogenic polypeptide is for gene therapy applications. DNA is incorporated into the microparticle without destruction of its function.